Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus

Metabolism: Clinical and Experimental

Volumn 56, Issue 12, 2007, Pages 1682-1688

  Kita, Yuki ^a   Mizukoshi, Eishiro ^a   Takamura, Toshinari ^a   Sakurai, Masaru ^a   Takata, Yoshiko ^a   Arai, Kuniaki ^a   Yamashita, Tatsuya ^a   Nakamoto, Yasunari ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTRIGLYCERIDEMIA; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYPERTRIGLYCERIDEMIA; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; OBESITY; RETROSPECTIVE STUDIES;

EID: 35848962291     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.011     Document Type: Article

References (41)

1. Kiyosawa K., Sodeyama T., Furuta S., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 (1990) 671-675
2. Tong M.J., el-Farra N.S., Reikes A.R., and Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332 (1995) 1463-1466
3. Niederau C., Lange S., Nawrocki M., et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28 (1998) 1687-1695
4. Wiese M., Berr F., Oesen U., et al. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
5. Poynard T., Ratziu V., Albrecht J., et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34 (2001) 730-739
6. Bissell D.M. Sex and hepatic fibrosis. Hepatology 29 (1999) 988-989
7. Wiley T.E., Brown J., and Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol 97 (2002) 700-706
8. Harris D.R., Gonin R., Seeff L.B., et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 134 (2001) 120-124
9. Ostapowicz G., Watson K.J., Desmond P.V., et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27 (1998) 1730-1735
10. Wiley T.E., McCarthy M., Layden T.J., et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28 (1998) 805-809
11. Corrao G., Lepore A.R., Arico S., et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 10 (1994) 657-664
12. Tsai J.F., Jeng J.E., Tsai J.H., et al. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 24 (1996) 271-276
13. Pontisso P., Gerotto M., Alberti A., et al. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 3 (1998) 137-142
14. Benhamou Y., Bochet M., Vidaud M., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30 (1999) 1054-1058
15. Ragni M.V., and Belle S.H. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 183 (2001) 1112-1115
16. Smith B.C., Gorve J., Bassendine M.F., et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27 (1998) 1695-1699
17. Matteoni C.A., Younossi Z.M., McCullough A.J., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
18. Kamal S., Madwar M., Rasenack J.W., et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20 (2000) 281-289
19. Kuzushita N., Hayashi N., Kaneshige T., et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27 (1998) 240-244
20. Hourigan L.F., Macdonald G.A., Powell E.E., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29 (1999) 1215-1219
21. El-Serag H.B., Tran T., and Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004) 460-468
22. Mason A.L., Lau J.Y., Guo L., et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29 (1999) 328-333
23. Hu K.Q., Kyulo N.L., Runyon B.A., et al. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol 40 (2004) 147-154
24. Hickman I.J., Powell E.E., Jonsson J.R., et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 39 (2003) 1042-1048
25. Narita R., Abe S., Otsuki M., et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 41 (2004) 132-138
26. Fartoux L., Poujol-Robert A., Serfaty L., et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 54 (2005) 1003-1008
27. Desmet V.J., Gerber M., Scheuer P.J., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
28. Araki T., Itai Y., Tasaka A., et al. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 135 (1980) 1037-1043
29. Misu H., Takamura T., Matsuzawa N., et al. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50 (2007) 268-277
30. Khalili M., Lim J.W., Terrault N.A., et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 10 (2004) 349-355
31. Delgado-Borrego A., Casson D., Bhan A., et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 77 (2004) 703-710
32. Thuluvath P.J., and John P.R. Association between hepatitis C, diabetes mellitus, and race. A case-control study. Am J Gastroenterol 98 (2003) 438-441
33. Mehta S.H., Brancati F.L., Szklo M., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38 (2003) 50-56
34. Zein C.O., Levy C., Zein N.N., et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 100 (2005) 48-55
35. Monto A., Alonzo J., Wright T.L., et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36 (2002) 729-736
36. Davila J.A., Morgan R.O., El-Serag H.B., et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54 (2005) 533-539
37. Hassan M.M., Hwang L.Y., Beasley P., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36 (2002) 1206-1213
38. Huo T.I., Lui W.Y., Lee S.D., et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 98 (2003) 2293-2298
39. Ota T., Takamura T., Kurita S., et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132 (2007) 282-293
40. Ikeda Y., Shimada M., Yanaga K., et al. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 27 (1998) 1567-1571
41. Toyoda H., Kumada T., Tanikawa M., et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 91 (2001) 957-963